I've purchased both papers and written reviews of the research on Facebook.
https://www.facebook.com/note.php?note_ ... 0489747211
https://www.facebook.com/note.php?note_ ... 0373787211
For those not on Facebook and interested in purchasing the reviews for themselves...link below.
http://www.thelancet.com/journals/laneu ... 7/fulltext
The most interesting development is the change of heart for MS researcher Massimo Filippi, co-author of the first negative review of Dr. Zamboni published in the Annals of Neurology in Feb 2010.
http://onlinelibrary.wiley.com/doi/10.1 ... 1/abstract
Filippi now writes about the vascular aspects of MS, how the ischemic injury to brain tissue appears to be primary , and need for more research and clinical trials for CCSVI.
For instance, in a combined perfusion and diffusion MRI study, there was an association between decreased perfusion and decreased mean diffusivity—a measure of tissue integrity—in the corpus callosum of patients with relapsing-remitting MS.7 This finding seems to be more consistent with what would be expected in primary ischaemia rather than as a result of secondary hypoperfusion associated with Wallerian degeneration.